Testis Male 60-69 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with Testis Male 60-69 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with Testis Male 60-69 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with Testis Male 60-69 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Testis Male 60-69 Up.

Results found

Linked to

 

Label

Description

 

Gene

RAD52 motif containing 1

Gene

SPATA31 subfamily C member 2

Gene

SPATA31 subfamily C member 1

Gene

small integral membrane protein 2

Gene

solute carrier organic anion transporter family member 6A1

Gene

serine/threonine kinase 31

Gene

transmembrane phosphoinositide 3-phosphatase and tensin homolog 2

Gene

olfactory receptor family 1 subfamily R member 1

Gene

WD repeat domain 87

Gene

catsper channel auxiliary subunit delta

  • Gene

    RAD52 motif containing 1


  • Gene

    SPATA31 subfamily C member 2


  • Gene

    SPATA31 subfamily C member 1


  • Gene

    small integral membrane protein 2


  • Gene

    solute carrier organic anion transporter family member 6A1


  • Gene

    serine/threonine kinase 31


  • Gene

    transmembrane phosphoinositide 3-phosphatase and tensin homolog 2


  • Gene

    olfactory receptor family 1 subfamily R member 1


  • Gene

    WD repeat domain 87


  • Gene

    catsper channel auxiliary subunit delta

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.